Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
Agenda & Minutes United Kingdom Human papillomavirus (HPV) Influenza COVID-19
Download:
Recommendation United Kingdom Human papillomavirus (HPV)
Download:
Agenda & Minutes France Typhoid Ebola Human papillomavirus (HPV)
Download:
Functioning United Kingdom Human papillomavirus (HPV)
Download:
meeting agenda Agenda & Minutes United Kingdom Ebola Yellow fever Influenza Tuberculosis Human papillomavirus (HPV)
Download:
meeting agenda Agenda & Minutes Australia Human papillomavirus (HPV)
Download:
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Download: